CD8A and neoplasm: It has been revealed that CSCs can evade CD8 + T lymphocyte recognition and attack by down-regulating MHC-I, a process that significantly diminishes the sensitivity of CSCs to CD8+ T cell-mediated cytotoxicity, thus allowing CSCs to escape immune surveillance and potentially leading to tumor recurrence or metastasis at a later stage (116).